IFNAR2 and COVID-19: Supporting evidence has emerged from studies focused on genes associated with COVID-19 severity, where a specific variant within the IFNAR2 gene (rs2236757) has been linked to poorer clinical outcomes (Pairo-Castineira et al., 2020; Fricke-Galindo et al., 2022).